Lombardi Comprehensive Cancer Center at Georgetown University is a clinical research site located in Washington D.C., District of Columbia, United States 20057.
Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.
Lombardi Comprehensive Cancer Center at Georgetown University has participated in 25 clinical trials with 1 currently active.
Therapeutic areas: Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6).
Sponsors: Children's Oncology Group, National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group.
Trust Score: 80/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Lombardi Comprehensive Cancer Center at Georgetown University has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Lombardi Comprehensive Cancer Center at Georgetown University has 25 clinical trials on record, with 1 currently active. Their work covers Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6).
Yes — Lombardi Comprehensive Cancer Center at Georgetown University holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.